Zimmer Biomet reports Q4 and FY2025 results; specifics not available in filing

ZIMMER BIOMET HOLDINGS, INC.

2025-FY EPS reported $3.55 vs consensus $2.42 ▲ beat (+46.7%)

Press release issued February 10, 2026, for quarter and year ended December 31, 2025.
Exhibit 99.1 containing financial results was not appended to this filing.
No specific revenue, EPS, or guidance figures are provided in the body of the 8-K.
Investors should refer to the separate press release for detailed financial data.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.